<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04519203</url>
  </required_header>
  <id_info>
    <org_study_id>R20006</org_study_id>
    <nct_id>NCT04519203</nct_id>
  </id_info>
  <brief_title>The Use of Surgical Pleth Index in Guiding Anesthesia in Gastroenterological Surgery</brief_title>
  <official_title>The Use of Surgical Pleth Index in Guiding Anesthesia in Gastroenterological Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>general electric healthcare Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical Pleth Index (SPI) is an intraoperative monitor aimed into detection of nociception&#xD;
      and guidance of intraoperative opioid administration. Using such a device opioid&#xD;
      administration could be potentially optimized during intraoperative period. this study will&#xD;
      aim to show whether SPI could be used to reduce unwanted events and lower opioid consumption&#xD;
      in gastroenterological surgery. The study will be blinded and randomized including two study&#xD;
      arms with either SPI monitoring included or standard monitoring alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are extensively monitored intraoperatively. Even though there are monitors for the&#xD;
      measurement of nociception, it has not gained wide acceptance partly because of limited and&#xD;
      scarce evidence on the efficacy and optimal use. Especially elderly patients undergoing major&#xD;
      operation might benefit from optimization of opioid administration. Surgical Pleth Index&#xD;
      (SPI) is an intraoperative monitoring aimed for detection of nociceptive stimulus.&#xD;
&#xD;
      The aim of this research is to study whether SPI could be used to guide opioid administration&#xD;
      in gastroenterological surgery. The study will consist of a total 80 patients which are&#xD;
      randomized into two groups. The study sample is based on power calculation for the reduction&#xD;
      of remifentanil consumption.&#xD;
&#xD;
      In the study group the opioid administration will be guided using a SPI based protocol. In&#xD;
      the control group the opioid administration will be based on standard monitoring and clinical&#xD;
      decision alone. The aim of the study will be to study whether opioid administration optimized&#xD;
      using SPI can lover need for anticholinergic drugs, reduce need for opioids or diminish the&#xD;
      amount of unwanted side effects postoperatively. The patients will be treated using target&#xD;
      controlled infusions of remifentanil and propofol.&#xD;
&#xD;
      The data will be collected intraoperatively using electronic software and using a study data&#xD;
      collection form by study personel. All study procedures will take place during operative&#xD;
      period.&#xD;
&#xD;
      The study power was calculated using a study comparing depth of anesthesia and depth of&#xD;
      nociception balance-controlled group into a group without these monitors. In the group with&#xD;
      monitoring the consumption of remifentanil was 9,5±3.8 mg/kg/h while in the unmonitored group&#xD;
      the consumption was 12.3 mg/kg/h(Chen, 2010). While taking into notice α= 0,005 and β=90% a&#xD;
      number of 39 patients in each group is needed. Based on these we chose 80 patients to be&#xD;
      included in the study.&#xD;
&#xD;
      All collected data will be used into statistical analysis ass applicable. Statistical&#xD;
      analysis plan describing the analytical principles and statistical techniques to be employed&#xD;
      in order to address the primary and secondary objectives, as specified in the study protocol&#xD;
      or plan.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients are randomized using sealed envelopes. The ramdomization will be kept blinded to the study subjects</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative remifentanil consumption</measure>
    <time_frame>intraoperative time</time_frame>
    <description>The consumption of the remifentanil intraoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>severe hypotension</measure>
    <time_frame>intraoperative time</time_frame>
    <description>MAP &lt;55 mmHg, or -30% from the baseline value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intermediate hypotension</measure>
    <time_frame>intraoperative time</time_frame>
    <description>MAP &lt;65 mmHg, or -20% from the baseline value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypertension</measure>
    <time_frame>intraoperative time</time_frame>
    <description>RRsys &gt;140 mmHg or +20 % from baseline value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bradycardia</measure>
    <time_frame>intraoperative time</time_frame>
    <description>Heart rate&lt;45</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tachycardia</measure>
    <time_frame>intraoperative time</time_frame>
    <description>Heart rate&gt;90</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inraoperative propofol consumption</measure>
    <time_frame>intraoperative time</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Desorientation/ grade of sedation during postoperative care treatment</measure>
    <time_frame>2-4 hours</time_frame>
    <description>The postoperative desoroentation during immediate post-operative period at postanesthesia care unit. Measured using modified aldrete score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>2-4 hours</time_frame>
    <description>The postoperative nausea and vomiting during immediate post-operative period at postanesthesia care unit. Measured using modified aldrete score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>2-4 hours</time_frame>
    <description>The postoperative opioid consumption during immediate post-operative period at postanesthesia care unit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fading of intraoperative relaxation</measure>
    <time_frame>intraoperative time</time_frame>
    <description>The characteristics of intraoperative relaxation using EMG measurement</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Intraoperative Complications</condition>
  <condition>Intraoperative Hypotension</condition>
  <condition>Intraoperative Hypertension</condition>
  <arm_group>
    <arm_group_label>SPI group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of patients where opioid consumption will be guided using SPI target</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of patients where only standard monitoring and patient reaction will be used to guide opioid administration during intraoperative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SPI</intervention_name>
    <description>Either standard monitoring alone or added with SPI</description>
    <arm_group_label>SPI group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard</intervention_name>
    <description>Standard monitoring alone</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to provide a written informed consent&#xD;
&#xD;
          -  Age 50 years or above&#xD;
&#xD;
          -  Laparoscopic or laparotomic surgery requiring intubation with an expected&#xD;
             intraoperative time at least two hours.&#xD;
&#xD;
          -  ASA classification 1-3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Implanted cardiac pacemaker or known condition with irregular heart rate at the time&#xD;
             of inclusion or induction&#xD;
&#xD;
          -  Chronic use of opioids&#xD;
&#xD;
          -  BMI &gt;35&#xD;
&#xD;
          -  Known allergy for study medications&#xD;
&#xD;
          -  Over 5 extrasystoles per minute at the time of induction or inclusion&#xD;
&#xD;
          -  The use of epidural catheter during the last one hour before surgery or need for&#xD;
             catheter intraoperatively (if new catheter is placed at the beginning of surgery test&#xD;
             dosage may be used without the need for patient exclusion)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jarkko Harju, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jarkko Harju, MD, PhD</last_name>
    <phone>+35831165368</phone>
    <email>jarkko.harju@fimnet.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarkko Harju, MD</last_name>
      <phone>00358331165368</phone>
      <email>jarkko.harju@fimnet.fi</email>
    </contact>
    <investigator>
      <last_name>Jarkko Harju, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2020</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nociception</keyword>
  <keyword>Intraoperative monitoring</keyword>
  <keyword>Surgical pleth index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Intraoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

